Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-06-30

Clinical Trial Update: Is Procardia XL 60 mg Q Daily Equivalent to 30 mg XL Given Twice Daily? [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating whether Procardia XL 60 mg once daily is equivalent to 30 mg XL given twice daily for hypertension in pregnancy and postpartum; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PROCARDIA XL (NIFEDIPINE)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Hypertension in Pregnancy, Hypertension in Postpartum | Phase 4 | Status: TERMINATED | Results posted: 2022-06-30